Why Choose Our CAR-T Treatment？

Relying on China’s leading CAR-T treatment technology and rich experience in serving international patients,
we provide you with a professional, safe, and efficient CAR-T treatment journey.

Treatment Advantages

Our CAR-T Treatment Advantages

Internationally Leading CAR-T Treatment Technology

• One of the first medical centers in China to carry out CAR-T therapy
• Have completed hundreds of CAR-T cell therapy cases, with rich clinical experience
• Cover all approved CAR-T products, providing patients with the optimal choice
• Participate in multiple international multicenter clinical trials, mastering the latest technologies

Top-tier CAR-T Treatment Team

• Hematologic malignancy experts with an average of over 25 years of professional experience
• The core CAR-T treatment team has completed professional training and certification
• Academic exchanges with top institutions such as MD Anderson and Memorial Sloan Kettering Cancer Center in the United States
• Published multiple SCI papers related to CAR-T therapy

Comprehensive Treatment Support System

• One-stop service from evaluation to follow-up
• Professional CRS and ICANS management team
• Multidisciplinary collaboration (MDT) to ensure the best treatment outcomes

High Cost-effective Medical Services

• The cost of CAR-T therapy is about 50–70% of that in European and American countries
• Domestic CAR-T products such as Axicabtagene and Relmacabtagene are more competitively priced
• Transparent fee structure, no hidden charges
• Multiple payment methods, assisting with international insurance claims

Fast and Convenient Medical Access Channel

• No long waiting required, fast arrangement for hospitalization
• Exclusive green channel for international patients
• The average period from consultation to infusion is only 4–6 weeks
• 24-hour professional consultation and emergency support

Comprehensive International Patient Services

• Multilingual service team (English, Arabic, Russian, etc.)
• Assistance with medical visa processing
• Airport pick-up and drop-off, accommodation arrangement, interpreter accompaniment
• Remote follow-up and continuous medical support

OUR TEAM

CAR-T Treatment Expert Team

Team Honors

• National Science and Technology Progress Award
• Multiple provincial and ministerial-level scientific achievement awards
• More than 10 patents related to CAR-T therapy
• More than 20 invited presentations at international academic conferences

• Chief physician, doctoral supervisor
• Engaged in clinical and research work in hematologic diseases for over 30 years
• Member of the China CAR-T Treatment Expert Committee
• Presided over multiple National Natural Science Foundation projects
• Published more than 100 SCI papers

• 3 associate chief physicians and 5 attending physicians
• All have completed international professional training in CAR-T therapy
• Cumulatively completed more than 500 CAR-T treatments
• Very rich experience in managing CAR-T-related adverse reactions

• Hematopoietic stem cell transplantation experts
• Cell preparation and quality control experts
• Cell therapy nursing team
• Infection control experts

• Imaging diagnosis experts: precisely evaluate treatment efficacy
• Pathology diagnosis experts: accurate subtype diagnosis
• Pharmacy experts: medication safety guidance
• Nutrition experts: personalized nutritional support
• Psychology experts: mental health support

• International medical department coordinators: full-process coordination services
• Professional medical interpreters: ensure barrier-free communication
• Patient service specialists: assist with daily living arrangements
• Follow-up specialists: long-term tracking and management

Relevant cases

Successful Case Sharing

Treatment Data Statistics

• Cumulative CAR-T treatments completed: 500+ cases
• Overall response rate (ORR): 75%
• Complete remission rate (CR): 50%
• 12-month progression-free
survival rate: 45%
• Grade 3–4 CRS incidence rate: 10%
• Grade 3–4 ICANS incidence rate: 8%
• Treatment-related mortality rate: <3%
• Patient satisfaction rate: 96%

Case 1: Patient with Relapsed/Refractory Multiple Myeloma Patient Background: 62-year-old male with multiple myeloma, relapsed after 4 lines of treatment

Treatment Plan: BCMA CAR-T (FUCASO®) therapy

Patient Testimonial: "FUCASO® treatment gave me new hope. Now I feel like I have been reborn."

Case 2: Patient with Relapsed B-ALL Patient Background: 16-year-old male, relapsed B-ALL, relapsed again after hematopoietic stem cell transplantation

Treatment Plan: CD19 CAR-T cell therapy

Patient Testimonial: "CAR-T therapy gave me a third life. Thank you to the medical team for your dedicated care!"

Case 3: Patient with Relapsed/Refractory DLBCL Patient Background: 58-year-old female, relapsed DLBCL, disease progression after 2 lines of treatment

Treatment Plan: CD19 CAR-T cell therapy

Patient Testimonial: "Although there were some challenges during treatment, the final result was worth it."

FAQS

FAQ Frequently Asked Questions

Q1: Why choose to receive CAR-T therapy in China?

China has world-leading CAR-T treatment technology and rich clinical experience, and the treatment cost is only 50–70% of that in European and American countries. Six CAR-T products have been approved in China, covering multiple types of hematologic malignancies, providing patients with more choices.

Q2: What is your CAR-T treatment success rate?

Our overall response rate of CAR-T therapy reaches 75%, and the complete remission rate is 50%, comparable to top international medical centers. We have extensive experience in managing CRS and ICANS, with high treatment safety.

Q3: What is the total cost of CAR-T therapy?

The cost of CAR-T therapy varies depending on the product type and patient condition, usually ranging between 150,000–250,000 USD, about 50–70% of that in European and American countries. We provide transparent cost evaluations and multiple payment options.

Q4：What do international patients need to prepare when coming to China for treatment?

We provide full-process services: medical visa assistance, medical record translation, airport pick-up and drop-off, accommodation arrangement, interpreter accompaniment, etc. You only need to bring complete medical records, and we will assist in handling the other matters.

Q5: How is follow-up conducted after treatment?

We provide long-term follow-up services, including regular re-examinations, remote consultations, relapse monitoring, etc. International patients can choose to undergo re-examinations locally and obtain medical advice through remote consultations.

What Is CAR-T？

Understand the Basic Knowledge of CAR-T Therapy—Comprehensive analysis of technical principles, indications, and treatment process

For What Kind of People？

Evaluate Whether You Are Suitable for Our Treatment—Understand treatment indications and patient evaluation criteria

Learn More About Hematologic Malignancies

Comprehensive analysis of disease types, diagnosis, and treatment

Real Patient Recovery Experiences

Read more successful cases to gain hope and confidence

Fill in the following information, and our expert team will contact you within 12 hours